Hepatic Disease in HIV-Infected Patients

  • Author: Mark S. Sulkowski, MD (More Info)
  • Editors in Chief: Daniel R. Kuritzkes, MD; Joseph J. Eron, Jr., MD
  • Last Reviewed: 9/4/18 (What's New)

Summary

  • Entecavir is approved in the United States and Europe for the treatment of chronic HBV infection in both HBV/HIV-coinfected and HBV-monoinfected persons

Action required